内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Lyra Therapeutics, Inc.

LYRA · — · CIK 0001327273 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

1 同一窗口内观察到的 Form 4 交易行
0 sales · 1 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2023-11-10 · Waksal Harlan · $74.0K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Smith W BradfordDirector
○
● 买入▼ 卖出○ 其他

—

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-11-10 · Waksal Harlan.

近期 Form 4 活动

0买入
14卖出
3其他 Form 4 交易行
7SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他1 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
4,882
上期报告
4,895
日均成交量
1,191
回补天数
4.1

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2023-11-10Waksal Harlan买入 (P)Common Stock25,000USD 2.96USD 74,000SEC 申报 ↗
2023-05-31EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC买入 (P)Common Stock3,610,832USD 2.49USD 8,990,972SEC 申报 ↗
2023-05-31DAMORE RICHARD A; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.; North Bridge Venture Partners VI L P买入 (P)Common Stock1,805,416USD 2.43USD 4,387,161SEC 申报 ↗
2023-05-31ANDERSON EDWARD T买入 (P)Common Stock1,805,416USD 2.43USD 4,387,161SEC 申报 ↗
2022-06-10MERRIFIELD C ANN买入 (P)Common Stock4,000USD 5.05USD 20,200SEC 申报 ↗
2022-05-16MERRIFIELD C ANN买入 (P)Common Stock328USD 5.00USD 1,640SEC 申报 ↗
2022-05-13MERRIFIELD C ANN买入 (P)Common Stock3,500USD 4.81USD 16,835SEC 申报 ↗
2022-04-12EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC买入 (P)Common Stock5,924,170USD 4.22USD 24,999,997SEC 申报 ↗
2022-04-12DAMORE RICHARD A; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.; North Bridge Venture Partners VI L P买入 (P)Common Stock2,369,667USD 4.22USD 9,999,995SEC 申报 ↗
2022-04-12ANDERSON EDWARD T买入 (P)Common Stock2,488,150USD 4.22USD 10,499,993SEC 申报 ↗
2022-04-12Waksal Harlan买入 (P)Common Stock236,966USD 4.22USD 999,997SEC 申报 ↗
2021-06-17MERRIFIELD C ANN买入 (P)Common Stock3,500USD 8.97USD 31,395SEC 申报 ↗
2020-12-16snyderman nancy lynn MD买入 (P)Common Stock1,025USD 9.72USD 9,963SEC 申报 ↗
2020-05-05EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC买入 (P)Common Stock625,000USD 16.00USD 10,000,000SEC 申报 ↗
2020-05-05Levy Guy; Soleus Capital Group, LLC; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus PE GP I, LLC; Soleus Private Equity Fund I, L.P.; Soleus Private Equity GP I, LLC买入 (P)Common Stock155,000USD 16.00USD 2,480,000SEC 申报 ↗

Form 4 申报证据

17 transaction lines in the latest 365-day window; 107 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-05-14Smith W BradfordD (D)Common Stock640USD 0.00USD 0SEC 申报 ↗
2026-04-01Palasis MariaD (D)Common Stock2,000USD 0.00USD 0SEC 申报 ↗
2026-04-01Cavalier JasonD (D)Common Stock667USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (11 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-05-14Smith W BradfordD (D)Common Stock640USD 0.00USD 0SEC 申报 ↗
2026-04-01Palasis MariaD (D)Common Stock2,000USD 0.00USD 0SEC 申报 ↗
2026-04-01Cavalier JasonD (D)Common Stock667USD 0.00USD 0SEC 申报 ↗
2026-01-06Palasis Maria卖出 (S)Common Stock1,702USD 3.36USD 5,719SEC 申报 ↗
2026-01-06Cavalier Jason卖出 (S)Common Stock769USD 3.36USD 2,584SEC 申报 ↗
2025-11-13EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock31,810USD 3.90USD 124,059SEC 申报 ↗
2025-11-12EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock8,745USD 4.06USD 35,505SEC 申报 ↗
2025-11-11EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock5,320USD 4.31USD 22,929SEC 申报 ↗
2025-11-10EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock18,502USD 4.54USD 83,999SEC 申报 ↗
2025-11-07EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock19,739USD 4.75USD 93,760SEC 申报 ↗
2025-11-06EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC卖出 (S)Common Stock32,149USD 5.18USD 166,532SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码LYRA
CIK0001327273
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
交易所—

数据覆盖

本地 Form 4 历史107 transaction lines from 2020-05-01 to 2026-05-14
34 P purchase lines · 27 S sale lines · 46 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.